Sales rise 15.52% to Rs 212.19 crore
Net profit of ERIS Lifesciences rose 20.52% to Rs 56.08 crore in the quarter ended March 2018 as against Rs 46.53 crore during the previous quarter ended March 2017. Sales rose 15.52% to Rs 212.19 crore in the quarter ended March 2018 as against Rs 183.69 crore during the previous quarter ended March 2017.For the full year,net profit rose 19.61% to Rs 294.98 crore in the year ended March 2018 as against Rs 246.61 crore during the previous year ended March 2017. Sales rose 14.16% to Rs 855.60 crore in the year ended March 2018 as against Rs 749.50 crore during the previous year ended March 2017. ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales212.19183.69 16 855.60749.50 14 OPM %33.8026.70 -37.6435.90 - PBDT71.2854.11 32 337.87293.15 15 PBT62.2147.61 31 312.23270.39 15 NP56.0846.53 21 294.98246.61 20
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)